Isomorphic Labs
-
Business & Markets · Enterprise Isomorphic Labs Announces $2.1B Funding to Scale its AI Drug Design Engine
Insider Brief PRESS RELEASE — Isomorphic Labs, an AI-first drug design and development company, has announced it has raised $2.1 Billion in Series B funding. This latest round of investment will accelerate the company’s evolution from… -
Business & Markets · Startups Isomorphic Labs Announces $600M Funding to Further Develop its Next-generation AI Drug Design Engine and Advance Therapeutic Programs into the Clinic
-
Technology & Infrastructure · Models & LLMs Isomorphic Labs Founder Sees AI-Designed Drug Entering Trials by Year-End
-
Technology & Infrastructure · Models & LLMs Google DeepMind Researchers Say AlphaFold 3 Represents a New Era in Molecular Biology And Drug Discovery
-
Technology & Infrastructure · Models & LLMs Isomorphic Labs Announces Strategic Multi-Target Research Collaboration With Novartis
The AI economy, every weekday morning
The daily briefing plus the weekly Scale-ups to watch edition. Free, no spam, unsubscribe any time.